» Authors » Manabu Ishii

Manabu Ishii

Explore the profile of Manabu Ishii including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 468
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawai K, Ishii M, Kokado Y, Horikawa T, Hoshino J
Kidney Int Rep . 2024 Jul; 9(7):2056-2066. PMID: 39081766
Introduction: The association of hemoglobin level at treatment initiation with renal and cardiovascular outcomes in patients with anemia in nondialysis-dependent (NDD) chronic kidney disease (CKD) is unclear. Methods: This retrospective...
2.
Suetake H, Tanjo T, Ishii M, Kinoshita B, Fujino T, Hachiya T, et al.
F1000Res . 2024 Jul; 11:889. PMID: 39070189
The increased demand for efficient computation in data analysis encourages researchers in biomedical science to use workflow systems. Workflow systems, or so-called workflow languages, are used for the description and...
3.
Katsumata R, Kaburagi T, Hosokawa T, Manabe N, Ishii M, Ishii K, et al.
Intern Med . 2024 Apr; 63(23):3149-3155. PMID: 38599865
Objective Gastrointestinal (GI) disorders such as functional dyspepsia (FD), irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) can exhibit overlapping GI symptoms, including abdominal pain...
4.
Takahashi A, Ishii M, Kino Y, Sasaki K, Matsui T, Arakawa K, et al.
Diabetes Ther . 2024 Mar; 15(5):1187-1199. PMID: 38554220
Introduction: Although the use of application (app)s and wearable devices supporting diabetes treatment has spread rapidly in recent years, evidence of their impact, especially in combination of them, is limited....
5.
Tsuyuzaki K, Ishii M, Nikaido I
BMC Bioinformatics . 2023 Nov; 24(1):420. PMID: 37936079
Background: Complex biological systems are described as a multitude of cell-cell interactions (CCIs). Recent single-cell RNA-sequencing studies focus on CCIs based on ligand-receptor (L-R) gene co-expression but the analytical methods...
6.
Oshima N, Hiraoka S, Hayashi R, Takahashi S, Ishii M, Hashimoto S, et al.
Inflamm Bowel Dis . 2023 Aug; 30(7):1087-1093. PMID: 37598298
Background: Tacrolimus (TAC), a calcineurin inhibitor, is used for remission induction therapy in patients with moderate to severe ulcerative colitis (UC), with short-term efficacy and related predictive factors shown in...
7.
Fujita M, Manabe N, Murao T, Suehiro M, Tanikawa T, Nakamura J, et al.
J Gastroenterol Hepatol . 2023 Jan; 38(5):775-782. PMID: 36706165
Background And Aim: The clinical severity and course of acute lower gastrointestinal bleeding (ALGIB) are believed to differ between inpatient-onset and outpatient-onset cases, but no reports have investigated these issues...
8.
Hachiya T, Ishii M, Kawai Y, Khor S, Kawashima M, Toyo-Oka L, et al.
Hum Genome Var . 2022 Dec; 9(1):48. PMID: 36539398
Accurate genotype imputation requires large-scale reference panel datasets. When conducting genotype imputation on the Japanese population, researchers can use such datasets under collaborative studies or controlled access conditions in public...
9.
Kokado Y, Ishii M, Ueta K, Yamamoto H, Kumamaru H, Isshiki M, et al.
Curr Med Res Opin . 2022 Sep; 38(12):2175-2182. PMID: 36111421
Objective: Anemia is a common complication of chronic kidney disease (CKD). The aim of this study was to evaluate hemoglobin levels at the initiation of erythropoiesis stimulating agent (ESA) therapy...
10.
Sakemi R, Miyakawa M, Tanaka H, Nasuno M, Motoya S, Tanuma T, et al.
Medicine (Baltimore) . 2020 Nov; 99(47):e23344. PMID: 33217875
This study aimed to investigate the short-term effectiveness of adalimumab therapy in patients with ulcerative colitis (UC), especially its rapid response.This retrospective, multicenter, cohort study involved 7 institutes in Japan,...